CaroGen reports that new preclinical data about the mechanism of action of its novel ovarian cancer immunotherapy, CARG-2020, will be presented in a plenary session of the Society of Gynecologic Oncology meeting on Women’s Cancer in Tampa, Florida on March 25-28, 2023.
“CARG-2020, working through specific immune mechanisms of action, has displayed impressive preclinical effectiveness in treating and preventing tumor recurrence,” said Professor Gil Mor of Wayne State University